A pooled analysis investigated the prognostic role of DNA mismatch repair status in patients with stage III colon cancer treated with a standard adjuvant chemotherapy regimen. READ MORE
A novel scoring system may identify elderly patients with advanced gastric cancer who may not benefit from chemotherapy.
A pilot program for Direct Access Colonoscopy Screening increased overall screening rates for colorectal cancer by nearly 100%.
Costs associated with maintenance bevacizumab and capecitabine.
A pooled analysis investigated the prognostic role of DNA mismatch repair status in patients with stage III colon cancer treated with a standard adjuvant chemotherapy regimen.
Recent research has uncovered an association between tumor origin and mortality among patients receiving systemic chemotherapy plus biologic therapy for metastatic colorectal cancer.
Sequencing cell-free DNA may be able to provide baseline information on actionable mutations and improve the quality of care in colorectal cancer.
A re-analysis of 2016 data from the USPSTF on colorectal cancer screening indicates that flexible sigmoidoscopy reduces the risk of death.
Research in Review
A recent study combined and analyzed data from three trials regarding the use of first-line chemotherapy plus selective internal radiotherapy in patients with colorectal cancer and liver metastases.
A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment.
A recent study compared the effects of first-line chemotherapy with two different drugs in patients with advanced or metastatic colorectal cancer.